Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China flag China · Delayed Price · Currency is CNY
19.01
-0.54 (-2.76%)
Nov 17, 2026, 3:00 PM CST

SHA:688062 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,3061,5281,1931,6512,49196.54
Short-Term Investments
--35.8735.26--
Trading Asset Securities
17.67-3.7714.8860.12-
Cash & Short-Term Investments
2,3241,5281,2321,7012,55196.54
Cash Growth
56.82%24.02%-27.56%-33.32%2542.47%-82.38%
Accounts Receivable
124.999.7938.3417.510.070.14
Other Receivables
112.15123.3100.05112.2782.6533.01
Receivables
237.05223.09138.39129.7882.7333.15
Inventory
186.72187.9211.68159.379.0540.11
Other Current Assets
151.0599.33122.8457.4865.1274.93
Total Current Assets
2,8992,0391,7052,0482,778244.74
Property, Plant & Equipment
1,8451,9702,0531,9351,263811.64
Long-Term Investments
85.0391.1446.6641.9520.218.95
Goodwill
118.77118.77118.77118.77118.77118.77
Other Intangible Assets
140.09146.06152.81139.72161.31179.4
Long-Term Deferred Charges
6.66.266.390.986.1312.71
Other Long-Term Assets
207.53184.69192.76170.98271.93209.07
Total Assets
5,3024,5564,2764,4554,6191,595

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
99.11197.38100.2362.3245.2139.69
Accrued Expenses
80.12145.03150.64138.1282.2557.53
Short-Term Debt
993.441,147921.6209.27100.1410.82
Current Portion of Long-Term Debt
448.09183.8113.651.590.60.15
Current Portion of Leases
-134.4131.5226.9621.0218.83
Current Income Taxes Payable
24.542.342.393.34--
Current Unearned Revenue
67.36288.5936.0113.5236.6563.53
Other Current Liabilities
181.38160.38185.67361.26159.2779.85
Total Current Liabilities
1,8942,2591,542816.39445.14270.41
Long-Term Debt
2,0991,3411,006887.72492.12132.05
Long-Term Leases
148.32165.94142.97167.11160.57172.72
Long-Term Unearned Revenue
35.6749.1927.0710.5911.0311.47
Other Long-Term Liabilities
229.99208.121.53---
Total Liabilities
4,4074,0232,7201,8821,109586.65

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
446.73399.6399.6399.6399.6299.7
Additional Paid-In Capital
-5,7605,9595,9315,8122,456
Retained Earnings
-6,443-5,765-4,795-3,751-2,698-1,743
Treasury Stock
-49.99-49.99----
Comprehensive Income & Other
6,7624.455.084.81.56-2.6
Total Common Equity
716.07349.511,5692,5843,5161,011
Minority Interest
179.04183.5-13.1-10.45-5.08-2.18
Shareholders' Equity
895.115331,5562,5733,5111,009
Total Liabilities & Equity
5,3024,5564,2764,4554,6191,595

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3,6882,9722,2161,293774.45334.58
Net Cash (Debt)
-1,365-1,444-983.91408.41,777-238.03
Net Cash Growth
----77.01%--
Net Cash Per Share
-3.26-3.62-2.461.024.54-0.79
Filing Date Shares Outstanding
445.54398.41399.6399.6399.6299.7
Total Common Shares Outstanding
445.54398.41399.6399.6399.6299.7
Working Capital
1,005-220163.471,2312,333-25.68
Book Value Per Share
1.610.883.936.478.803.37
Tangible Book Value
457.2184.681,2972,3253,236712.64
Tangible Book Value Per Share
1.030.213.255.828.102.38
Buildings
-754.31753.02181.833.063.06
Machinery
-1,2211,206653.69440.39420.08
Construction In Progress
-348.36240.871,131804.49313.24